Quarterly report pursuant to Section 13 or 15(d)

Related Party Agreements (Narrative) (Details)

v3.20.2
Related Party Agreements (Narrative) (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Jul. 22, 2016
Jun. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Related Party Transaction [Line Items]              
Proceeds from issuance of common shares           $ 37,230 $ 31,625
At the Market Offering [Member]              
Related Party Transaction [Line Items]              
Proceeds from issuance of common shares           8,000 $ 22,500
Public Offering [Member]              
Related Party Transaction [Line Items]              
Proceeds from issuance of common shares           $ 37,200  
Common Shares [Member]              
Related Party Transaction [Line Items]              
Issuance of common shares - Founders Agreement (in shares)           1,206,667 709,314
Class A Preferred Stock [Member]              
Related Party Transaction [Line Items]              
Issuance of common shares - Founders Agreement (in shares)           0  
Fortress Biotech, Inc [Member]              
Related Party Transaction [Line Items]              
Percentage of annual fees expense related to Management Services Agreement recorded in research and development expenses     50.00%   50.00% 50.00% 50.00%
Percentage of annual fees expense related to Management Services Agreement recorded in general and administrative expenses     50.00%   50.00% 50.00% 50.00%
Share of equity or debt financing used to calculate equity fee or stock issuance to maintain parity (as a percent) 2.50%            
Fortress Biotech, Inc [Member] | Issuance Related to Debt Financing [Member]              
Related Party Transaction [Line Items]              
Share of equity or debt financing used to calculate equity fee or stock issuance to maintain parity (as a percent)       2.50%      
Issuance of common shares - Founders Agreement (in shares)       31,220      
Proceeds from issuance of common shares       $ 5,000      
Fortress Biotech, Inc [Member] | At the Market Offering [Member]              
Related Party Transaction [Line Items]              
Share of equity or debt financing used to calculate equity fee or stock issuance to maintain parity (as a percent)   2.50%          
Issuance of common shares - Founders Agreement (in shares)   22,170          
Proceeds from issuance of common shares   $ 3,000          
Fortress Biotech, Inc [Member] | Public Offering [Member]              
Related Party Transaction [Line Items]              
Share of equity or debt financing used to calculate equity fee or stock issuance to maintain parity (as a percent)   2.50%          
Issuance of common shares - Founders Agreement (in shares)   286,390          
Proceeds from issuance of common shares   $ 37,200          
Fortress Biotech, Inc [Member] | General and Administrative [Member] | Issuance Related to Debt Financing [Member]              
Related Party Transaction [Line Items]              
Expenses from related party transaction       $ 100   $ 100  
Fortress Biotech, Inc [Member] | General and Administrative [Member] | At the Market Offering [Member]              
Related Party Transaction [Line Items]              
Expenses from related party transaction           100  
Fortress Biotech, Inc [Member] | General and Administrative [Member] | Public Offering [Member]              
Related Party Transaction [Line Items]              
Expenses from related party transaction           $ 900